Island Pharma has been granted the regulatory approvals needed to allow compassionate use of its antiviral galidesivir in the ...

Though they are still primarily prescribed for weight loss and diabetes, researchers are looking at the effects of GLP-1s for a wide variety of conditions from substance abuse dis ...

Let me start with something most strategy decks dance around: the patent cliff isn't the problem. It's the symptom. Every ...

As practising oncologists, we've seen firsthand how a cancer diagnosis changes the way patients engage with information.

For more than a century, tissue biopsies have stood as the gold standard for diagnosing cancer. And for good reason. These tiny tumour samples can unlock a wealth of molecular information, information ...

Vertex Pharma has made the largest acquisition in its history, agreeing to buy Crinetics Pharma for around $10 billion in a ...

Women with endometriosis in England could soon be offered simple non-invasive tests for diagnosis of their condition, rather ...

This month, the European Commission granted centralised marketing authorisation for Zandoriah (teriparatide), a biosimilar to ...

Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO, whilst ...

Novartis has reached a deal to buy Myricx Bio for up to $1.5 billion, giving it control of the London, UK, start-up's ...

Roche's Genentech unit has forged an alliance with Astex, worth up to $515 million, to partner on a fragment-based drug ...

Sir Chris Hoy has said he feels "very proud" when he hears of people taking part in the charity cycling event he set up last ...